"済生会京都府病院は、乙訓地域の基幹的な総合医療施設として、「出産」から「看取り」まで、地域の医療機関と連携しながら安心・安全の医療を切れ目なく提供し、地域包括ケアの整備を進め、暮らしやすく活力ある地域の発展・まちづくりに取り組みます 《地域医療支援病院・京都府がん診療推進病院・災害拠点病院・臨床研修指定病院》"

During the past decade, Saiseikai Kyoto Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Saiseikai Kyoto Hospital" are "Carotid Artery Diseases" (1 trials), "Gastric Cancer" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Saiseikai Kyoto Hospital" in a lesser frequency.

Most popular intervention types in "Saiseikai Kyoto Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Krestin (PSK)" (1 trials), "Pitavastatin" (1 trials) and "Tegafur-gimeracil-oteracil potassium (TS-1)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saiseikai Kyoto Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Saiseikai Kyoto Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Saiseikai Kyoto Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saiseikai Kyoto Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".